
Gilead, PEPFAR Partner to Provide Twice-Yearly HIV Prevention for 2M People
Gilead Partners With PEPFAR to Expand Access to Twice-Yearly Lenacapavir for HIV Prevention in Low- and Middle-Income Countries Gilead Sciences, has announced a landmark partnership with the U.S. Department of State and the U.S. President’s Emergency Plan for AIDS Relief…











